Cellular Origins and Fresenius Kabi have successfully completed the first phase of a collaboration first announced in October 2024. The partnership was designed to help scale cell and gene therapy (CGT) manufacturing using advanced robotics and cell processing technologies. Signifying the partnership’s first phase, the companies said, is completion of digital and physical integration of one system from each. Namely, Fresenius Kabi’s cell processing system, Cue, has been integrated with Cellul...